There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Larimar Therapeutics ( ...

Larimar Therapeutics' CTI-1601 offers hope for Friedreich's ataxia patients, with promising trial results. Check out why LRMR ...

On Wednesday, Larimar Therapeutics Inc (LRMR) stock saw a modest uptick, ending the day at $7.71 which represents a slight increase of $0.29 or 3.91% from the prior close of $7.42. The stock opened at ...

Shares of Larimar Therapeutics (NASDAQ:LRMR) gained on Wednesday after Oppenheimer launched the company with an Outperform recommendation, citing the potential of its lead asset, nomlabofusp, targeted ...

Fintel reports that on October 16, 2024, Oppenheimer initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a ...

Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Brazil’s National Petroleum Agency (ANP) is looking to add three new pre-salt areas to the growing list of exploration blocks ...

Autumn is one of the most beautiful seasons in southern Burgenland. In addition to a colorful natural spectacle, numerous ...

On Thursday, Larimar Therapeutics (NASDAQ:LRMR) shares received an Outperform rating from Wedbush with a price target set at $22. The biopharmaceutical company, focused on the development of ...

Fintel reports that on October 2, 2024, HC Wainwright & Co. initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a Buy recommendation. As of September 25, 2024, the average one-year ...

We have a Full Moon in Aries on October 17 influencing every zodiac sign's weekly love horoscope between October 14 - 20, ...